 |
Previous Article | Next Article 
Volume 17, Number 9,
Issue of May 1, 1997
pp. 3343-3351
Copyright ©1997 Society for Neuroscience
Antipyretic Role of Endogenous Melanocortins Mediated by Central
Melanocortin Receptors during Endotoxin-Induced Fever
Received Sept. 13, 1996; revised Jan. 17, 1997; accepted Feb. 19, 1997.
Qin-Heng Huang1,
Margaret L. Entwistle1,
John D. Alvaro2,
Ronald S. Duman2,
Victor J. Hruby3, and
Jeffrey B. Tatro1
1 Division of Endocrinology, Diabetes, Metabolism and
Molecular Medicine, Tufts University School of Medicine and New England
Medical Center Hospitals, Boston, Massachusetts 02111, 2 Laboratory of Molecular Psychiatry, Departments of
Psychiatry and Pharmacology, Yale University School of Medicine, New
Haven, Connecticut 06508, and 3 Department of Chemistry,
University of Arizona, Tucson, Arizona 85721
Bacterial infection causes fever, an adaptive but potentially
self-destructive response, in the host. Also activated are
counterregulatory systems such as the pituitary-adrenal axis.
Antipyretic roles have also been postulated for certain endogenous
central neuropeptides, including the melanocortins ( -MSH-related
peptides). To test the hypothesis that endogenous central melanocortins
have antipyretic effects mediated by central melanocortin receptors
(MCRs), we determined the effect of intracerebroventricular injection
of a synthetic MCR antagonist,
Ac-Nle4,c-[Asp5,DNal(2 )7,Lys10] -MSH(4-10)-NH2
(SHU-9119) in endotoxin-challenged rats. The efficacy and specificity
of SHU-9119 as an MCR antagonist in the rat was first validated
in vitro and in vivo. In vitro, in
heterologous cells expressing either rat MC3-R or MC4-R, the major MCR
subtypes expressed in brain, SHU-9119 showed no intrinsic agonism, but it inhibited -MSH-induced cAMP accumulation (IC50 = 0.48 ± 0.19 and 0.41 ± 0.28 nM, respectively)
and
[125I]-[Nle4,DPhe7]- -MSH
binding (IC50 = 1.0 ± 0.1 and 0.9 ± 0.3 nM, respectively). In vivo, exogenous
-MSH (180 pmol) inhibited fever in rats when administered
intracerebroventricularly 30 min after Escherichia coli
lipopolysaccharide (LPS) (25 µg/kg, i.p.). When co-injected with
-MSH, SHU-9119 (168 pmol, i.c.v.) prevented the antipyretic action
of exogenous -MSH. In contrast, neither -MSH nor SHU-9119, alone
or in combination, affected body temperatures in afebrile rats. In
LPS-treated rats, intracerebroventricular injection of SHU-9119
significantly increased fever, whereas intravenous injection of the
same dose of SHU-9119 had no effect. Neither intracerebroventricular nor intravenous SHU-9119 significantly affected LPS-stimulated plasma
ACTH or corticosterone levels. The results indicate that endogenous
central melanocortins exert an antipyretic influence during fever by
acting on MCRs located within the brain, independent of any modulation
of the activity of the pituitary-adrenal axis.
Key words:
fever;
endotoxin;
melanocortin receptor;
pituitary-adrenal axis;
neuroimmunomodulation;
-MSH;
SHU-9119
This article has been cited by other articles:

|
 |

|
 |
 
T. Brzoska, T. A. Luger, C. Maaser, C. Abels, and M. Bohm
{alpha}-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases
Endocr. Rev.,
August 1, 2008;
29(5):
581 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Cone
Studies on the Physiological Functions of the Melanocortin System
Endocr. Rev.,
December 1, 2006;
27(7):
736 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Vulliemoz, E. Xiao, L. Xia-Zhang, M. Ferin, and S. L. Wardlaw
Melanocortin Modulation of Inflammatory Cytokine and Neuroendocrine Responses to Endotoxin in the Monkey
Endocrinology,
April 1, 2006;
147(4):
1878 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Grill, J. S. Carmody, L. Amanda Sadacca, D. L. Williams, and J. M. Kaplan
Attenuation of lipopolysaccharide anorexia by antagonism of caudal brain stem but not forebrain GLP-1-R
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2004;
287(5):
R1190 - R1193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fekete, B. Gereben, M. Doleschall, J. W. Harney, J. M. Dora, A. C. Bianco, S. Sarkar, Z. Liposits, W. Rand, C. Emerson, et al.
Lipopolysaccharide Induces Type 2 Iodothyronine Deiodinase in the Mediobasal Hypothalamus: Implications for the Nonthyroidal Illness Syndrome
Endocrinology,
April 1, 2004;
145(4):
1649 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton
Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
Pharmacol. Rev.,
March 1, 2004;
56(1):
1 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Zigman and J. K. Elmquist
Minireview: From Anorexia to Obesity--The Yin and Yang of Body Weight Control
Endocrinology,
September 1, 2003;
144(9):
3749 - 3756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Sinha, H. B. Schioth, and J. B. Tatro
Activation of central melanocortin-4 receptor suppresses lipopolysaccharide-induced fever in rats
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2003;
284(6):
R1595 - R1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Xiao, L. Xia-Zhang, N. R. Vulliemoz, M. Ferin, and S. L. Wardlaw
Agouti-Related Protein Stimulates the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Enhances the HPA Response to Interleukin-1 in the Primate
Endocrinology,
May 1, 2003;
144(5):
1736 - 1741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Marks, A. A. Butler, R. Turner, G. Brookhart, and R. D. Cone
Differential Role of Melanocortin Receptor Subtypes in Cachexia
Endocrinology,
April 1, 2003;
144(4):
1513 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Lechan and J. B. Tatro
Editorial: Hypothalamic Melanocortin Signaling in Cachexia
Endocrinology,
August 1, 2001;
142(8):
3288 - 3291.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Wisse, R. S. Frayo, M. W. Schwartz, and D. E. Cummings
Reversal of Cancer Anorexia by Blockade of Central Melanocortin Receptors in Rats
Endocrinology,
August 1, 2001;
142(8):
3292 - 3301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kiriyama, H. Tsuchiya, T. Murakami, K. Satoh, and Y. Tokumitsu
Calcitonin Induces IL-6 Production via Both PKA and PKC Pathways in the Pituitary Folliculo-Stellate Cell Line
Endocrinology,
August 1, 2001;
142(8):
3563 - 3569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Vrinten, W. H. Gispen, G. J. Groen, and R. A. H. Adan
Antagonism of the Melanocortin System Reduces Cold and Mechanical Allodynia in Mononeuropathic Rats
J. Neurosci.,
November 1, 2000;
20(21):
8131 - 8137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Murphy, C. N. Nunes, J. J. Ronan, M. Hanaway, A. M. Fairhurst, and T. N. Mellin
Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat
J Appl Physiol,
July 1, 2000;
89(1):
273 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Hohmann, T. H. Teal, D. K. Clifton, J. Davis, V. J. Hruby, G. Han, and R. A. Steiner
Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2000;
278(1):
R50 - R59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, M. Hirasawa, Y. Takahashi, R. Landgraf, and Q. J. Pittman
Suppression of PGE2 fever at near term: reduced thermogenesis but not enhanced vasopressin antipyresis
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 1999;
277(2):
R354 - R361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oosterom, W. A. J. Nijenhuis, W. M. M. Schaaper, J. Slootstra, R. H. Meloen, W. H. H. Gispen, J. P. H. Burbach, and R. A. H. Adan
Conformation of the Core Sequence in Melanocortin Peptides Directs Selectivity for the Melanocortin MC3 and MC4 Receptors
J. Biol. Chem.,
June 11, 1999;
274(24):
16853 - 16860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Haskell-Luevano, P. Chen, C. Li, K. Chang, M. S. Smith, J. L. Cameron, and R. D. Cone
Characterization of the Neuroanatomical Distribution of Agouti-Related Protein Immunoreactivity in the Rhesus Monkey and the Rat
Endocrinology,
March 1, 1999;
140(3):
1408 - 1415.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Q.-H. Huang, V. J. Hruby, and J. B. Tatro
Role of central melanocortins in endotoxin-induced anorexia
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 1999;
276(3):
R864 - R871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-H. Huang, V. J. Hruby, and J. B. Tatro
Systemic alpha -MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 1998;
275(2):
R524 - R530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. van der Kraan, R. A. H. Adan, M. L. Entwistle, W. H. Gispen, J. P. H. Burbach, and J. B. Tatro
Expression of Melanocortin-5 Receptor in Secretory Epithelia Supports a Functional Role in Exocrine and Endocrine Glands
Endocrinology,
May 1, 1998;
139(5):
2348 - 2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Ludwig, K. G. Mountjoy, J. B. Tatro, J. A. Gillette, R. C. Frederich, J. S. Flier, and E. Maratos-Flier
Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus
Am J Physiol Endocrinol Metab,
April 1, 1998;
274(4):
E627 - E633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Ollmann, M. L. Lamoreux, B. D. Wilson, and G. S. Barsh
Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo
Genes & Dev.,
February 1, 1998;
12(3):
316 - 330.
[Abstract]
[Full Text]
|
 |
|
|